Enjoy complimentary customisation on priority with our Enterprise License!
The Global Epigenetics Market size is estimated to grow at a CAGR of 14.06% between 2022 and 2027. The size of the market is forecasted to increase by USD 1,148.2 million. The growth of the market depends on several factors, including rising epigenetic applications in non-oncology diseases, increasing prevalence of CVDs, and the increase in strategic collaboration and M&A.
This epigenetics market report extensively covers market segmentation by application (oncology and non-oncology), product (reagents, kits, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Epigenetics Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bio Rad Laboratories Inc. - The company offers epigenetic analysis research, which involves study alterations in DNA methylation, DNA protein interactions, chromatin accessibility, and histone modifications.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the oncology segment will be significant during the forecast period. The increasing prevalence of cancer will increase the adoption of epigenetics. Cancer is caused by a variety of factors, including genetics, lifestyle choices, and exposure to certain environmental factors. Epigenetics solutions help in identifying diseases such as cancer.
Get a glance at the market contribution of various segments Request a PDF Sample
The oncology segment was valued at USD 433.60 million in 2017 and continued to grow by 2021. Many researchers are working on identifying and categorizing epigenetic patterns linked to cancer, and each identified change must be confirmed in many patients. Therefore, the demand for epigenetics solutions is expected to rise in the oncology segment. These factors will drive the growth of the segment during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to account for 40% of the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The rising incidence of chronic diseases, increasing healthcare expenditure, and the presence of key vendors are leading to a rise in the use of epigenetics in North America. Leading biotechnology and life sciences companies export epigenetics instruments to other regions, such as Asia and South America. The large number of clinical trials is also driving the demand for epigenetics across North America.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. COVID-19 led to supply chain and market disruptions for epigenetics consumables and instruments, which adversely impacted the regional market growth in 2020. However, the increasing adoption of genome sequencing technology for monitoring the spread of COVID-19 and the rising healthcare expenditure globally are boosting the demand for epigenetics solutions. Moreover, operations in the market were resumed after mass vaccination drives and ease of lockdown measures. These factors are expected to boost the growth of the epigenetics market in North America during the forecast period.
The epigenetics market research report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
|
Epigenetics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
163 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 14.06% |
|
Market growth 2023-2027 |
USD 1,148.2 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
12.85 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 40% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioVision Inc., CellCentric Ltd., Enzo Biochem Inc., EpiGentek Group Inc., F. Hoffmann La Roche Ltd., Hologic Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Zymo Research Corp. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
